Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease

Annals of Thoracic Surgery

Volumn 68, Issue 3, 1999, Pages 830-836

  Symes, James F ^a   Losordo, Douglas W ^a   Vale, Peter R ^a   Lathi, Kishor G ^b   Esakof, Darryl D ^a   Mayskiy, Michael ^a   Isner, Jeffrey M ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; VASCULOTROPIN;

ADULT; AGED; ANGINA PECTORIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DNA TRANSFECTION; FEMALE; GENE THERAPY; GENE TRANSFER; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SAFETY; THORACOTOMY;

EID: 0032698604     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00807-3     Document Type: Conference Paper

References (21)

1. Takeshita S., Weir L., Chen D., et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun. 227:1996;628-635.
2. Tsurumi Y., Takeshita S., Chen D., et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 94:1996;3281-3290.
3. Tio R.A., Lebherz C., Scheuermann T., et al. Evidence of collateral development following intramyocardial gene therapy with vascular endothelial growth factor. Surg Forum. 49:1998;220-221.
4. Baumgartner I., Pieczek A., Manor O., et al. Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1998;1114-1123.
5. Isner J.M., Baumgartner I., Rauh G., et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor preliminary clinical results . J Vasc Surg. 28:1998;964-975.
6. Germano G., Kiat H., Kavanagh P.B., et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 36:1995;2138-2147.
7. Hashimoto E., Ogita T., Nakaoka T., et al. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol. 267:1994;H1948-H1954.
8. Hockel M., Schlengerk K., Doctrow S., Kissel T., Vaupel P. Therapeutic angiogenesis. Arch Surg. 128:1993;423-429.
9. Takeshita S., Zheng L.P., Brogi E., et al. Therapeutic angiogenesis a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model . J Clin Invest. 93:1994;662-670.
10. Takeshita S., Pu L.-Q., Zheng L., et al. Vascular endothelial growth factor induces dose-dependent revascularization in a rabbit model of persistent limb ischemia. Circulation. 90:1994;228-234.
11. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
12. Pearlman J.D., Hibberd M.G., Chuang M.L., et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1:1995;1085-1089.
13. Tischer E., Mitchell R., Hartmann T., et al. The human gene for vascular endothelial growth factor multiple protein forms are encoded through alternative exon splicing . J Biol Chem. 266:1991;11947-11954.
14. Isner J.M., Pieczek A., Schainfeld R., et al. Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165. Lancet. 348:1996;370-374.
15. Hariawala M., Horowitz J.R., Esakof D., et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 63:1996;77-82.
16. Losordo D.W., Vale P.R., Symes J.F., et al. Gene therapy for myocardial angiogenesis. Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 98:1998;2800-2804.
17. Schumacher B., Pecher P., von Specht B.U., et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors first clinical results of a new treatment of coronary heart disease . Circulation. 97:1998;645-650.
18. Selke F.W., Laham R.J., Edelman E.R., et al. Therapeutic angiogenesis with basic fibroblast growth factor technique and early results . Ann Thorac Surg. 65:1998;1540-1544.
19. Giordano F.J., Ping P., McKirnan D., et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2:1996;534-539.
20. Mack C.A., Patel S.R., Schwaz E.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complimentary deoxyribonucleic and for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 115:1998;168-177.
21. Vale P.R., Rauh G.F., Wuensch D.I., et al. Influence of vascular endothelial growth factor on diabetic retinopathy. [Abstract] Circulation. 98:1998;353.